- Home
- XMTR vs LENZ Comparison
XMTR vs LENZ Comparison
Compare XMTR & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XMTR | LENZ |
|---|---|---|
| Founded | 2013 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 278.4M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XMTR | LENZ |
|---|---|---|
| Price | $88.97 | $7.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $58.60 | $44.00 |
| AVG Volume (30 Days) | 851.5K | ★ 857.4K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.95 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $686,631,000.00 | $19,088,000.00 |
| Revenue This Year | $23.76 | $50.42 |
| Revenue Next Year | $18.38 | $197.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.87 | N/A |
| 52 Week Low | $29.60 | $6.61 |
| 52 Week High | $93.13 | $50.19 |
Technical Indicators
Market Signals| Indicator | XMTR | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 73.32 | 39.02 |
| Support Level | $41.85 | N/A |
| Resistance Level | N/A | $10.42 |
| Average True Range (ATR) | 5.38 | 0.65 |
| MACD | 0.95 | -0.10 |
| Stochastic Oscillator | 89.48 | 22.42 |
Price Performance
Historical ComparisonAbout XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.